Diagnostics-World
Twitter   LinkedIn Facebookinstagram RSS  
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • Post a Press Release
    • View Press Releases
    • Submit a Story
    • Reprint Articles
  • Advertise
    • Media Kit
    • Digital Advertising Opportunities
    • Lead Generation
    • Whitepapers
    • Webinars
    • Podcasts
    • Editorial Calender
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside Ebooks
  • Events
    • Webinars
    • Industry Events
    • Dx Conferences
    • Tri-Conference
    • Next Generation Dx
    • Dx Innovation Summit
  • About
    • Editorial Profile
    • Editorial Calender
    • Contact
  • Molecular Med Tri-Conference
 
  • Pac-Man-Like CRISPR Enzymes Have Potential For Disease Diagnostics

    Berkeley News | University of California, Berkeley, researchers have described 10 new CRISPR enzymes that, once activated, behave like Pac-Man to chew up RNA in a way that could be used as sensitive detectors of infectious viruses.

    May 5, 2017
  • Caris Life Sciences On Diagnosing The Complexity Of The Molecular System

    Diagnostics World | Caris Life Sciences has tested over 110,000 cancer patients using the company’s Caris Molecular Intelligence test suite, which provides relevant, clinically actionable, and individualized treatment information to personalize cancer care for all solid tumors.

    May 4, 2017
  • New Sepsis Management Bundle Aims To Transform The Way Sepsis Is Treated

    Diagnostics World Contributed Commentary | In an effort to increase awareness surrounding sepsis and to reduce associated hospital costs, the Center of Medicaid and Medicare Services released a new sepsis management bundle in 2016 as part of the Hospital Inpatient Quality Reporting program.

    May 2, 2017
  • Quest Diagnostics CIO Harnesses Insights And Technology For Better Healthcare Results

    Forbes | Quest Diagnostics CIO Lidia Fonseca is a Forbes CIO Innovation Award winner on the strength of the role she has played in developing Quanum, a suite of technology and data analytics solutions offering a better understanding of how the company can provide critical insights in healthcare.

    May 1, 2017
  • Corning, Mobidiag, Illumina, And More: News From April 2017

    Diagnostics World Brief | News, products, and partnerships from around the diagnostics community including news from Corning, Mobidiag, Illumina, and more.

    Apr 27, 2017
  • Blood Tests Track Lung Cancer Gene Changes Aiding Treatment

    STAT | Liquid biopsies were able to detect some recurrences of lung cancer up to a year before imaging scans could, in a new study.

    Apr 26, 2017
  • This Is Neat: Billionaire Vinod Khosla Is Betting On A Handheld Diagnostic Test

    Forbes | Vinod Khosla, the billionaire Sun Microsystems founder and venture capitalist, is today leading a $24.5 million financing of a whimsically named diagnostic company, Two Pore Guys, that he says could fulfill a long-held goal: making the blood test business more like the software industry.

    Apr 25, 2017
  • The Sad Myth of the Direct to Consumer Startup

    THCB | If I had a dollar for every entrepreneur to whom I said, "Dear God, please don't rely on a direct to consumer strategy or your a doomed"... I wouldn't have to work anymore.

    Apr 24, 2017
  • Hannes Smarason On The Future Of The Platform For WuXi NextCODE

    Diagnostics World News | “We’re taking a slightly broader view of the world than we perhaps have done in the past,” Hannes Smarason, WuXi NextCode’s newly-minted CEO, told Diagnostics World earlier this month. That’s almost a challenge for a company with outposts in Reykjavik, Iceland; Shanghai, China; and Cambridge, Massachusetts, and whose provenance traces back to DeCODE Genetics on the Icelandic side and WuXi AppTech on the Chinese side.

    Apr 21, 2017
  • When Even Genome Sequencing Doesn’t Give a Diagnosis

    MIT Technology Review | The technology has been touted as a powerful diagnostic tool, but it doesn't provide answers to everyone.

    Apr 21, 2017
  • GRAIL Initiates STRIVE Study To Advance Development Of Blood Tests To Detect Cancer Early

    Diagnostics World Brief | GRAIL today announced that it has commenced its second multi-center clinical study, the STRIVE Study, to facilitate the development of GRAIL’s blood tests for early-stage cancer detection.

    Apr 20, 2017
  • Congenica And Edico Partner To Speed “DNA to Diagnosis” Analysis For Inherited Diseases

    Diagnostics World Brief | Congenica and Edico Genome today announced the companies have partnered to offer their complementary platform technologies as an all-in-one, genome data analysis solution that accelerates clinical labs’ and hospitals’ progression from DNA sequencing to diagnosis for inherited diseases which otherwise takes months or years.

    Apr 20, 2017
  • Research Paves The Way For Improved Non-Invasive Test For Colorectal Cancer

    Diagnostics World Brief | Researchers at Baylor College of Medicine and other institutions have identified specific types of bacteria that seem to be abundant in individuals with colorectal cancer.

    Apr 19, 2017
  • Theranos Settles With CMS For $30,000

    Business Insider | As part of the settlement, Theranos has to pay $30,000, and the company won't be able to own or a clinical lab within the next two years.

    Apr 18, 2017
  • Fred Hutch Spinout Analyzes Live Cells Of A Patients Cancer To Make Treatment More Effective

    GeekWire | There are hundreds of drugs that treat cancer, and every patient reacts differently to each of them. SEngine Precision Medicine, a Seattle startup spun out of the Fred Hutchinson Cancer Research Center, aims to help with a new test called PARIS.

    Apr 14, 2017
  • Qualcomm Tricorder XPRIZE Names Two Winners

    Diagnostics World News | The Qualcomm Tricorder XPRIZE announced winners at a ceremony yesterday. Final Frontier Medical Devices and Dynamical Biomarkers Group were both named winners.

    Apr 13, 2017
  • FDA Grants Emergency Use Authorization To Nanobiosym For Zika Virus Test

    Diagnostics World Brief | Nanobiosym announced that the U.S. Food and Drug Administration has issued an Emergency Use Authorization for the Gene-RADAR Zika Virus Test.

    Apr 13, 2017
  • «
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166 (current)
  • 167
  • 168
  • 169
  • 170
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy